Genentech, Inc.

1479 articles with Genentech, Inc.

• Lexicon Genetics Incorporated Expands Alliance With Genentech, Inc. To Discover And Develop Biotherapeutic Drugs; Lexicon To Receive $25 Million

  12/1/2005

• UK Biotech PIramed Signs $230 Million Genentech, Inc. Deal

  11/30/2005

• Montgomery & Co., LLC Initiates Coverage On Genentech, Inc.

  11/23/2005

• Nothing Like A Room Full Of Brainiacs To Make A Columnist Feel Small

  11/21/2005

• Biogen Idec, Inc. (Massachusetts) And Genentech, Inc. Cancer Drug Helps Arthritis

  11/14/2005

• Biogen Idec, Inc. (Massachusetts) And Genentech, Inc. Announce November 16th Webcast Discussion Of Rituxan Data Presented At ACR

  11/10/2005

• The Day In Review: More Good Data For Lucentis From Genentech

  11/8/2005

• Genentech, Inc. Says Ready To Seek FDA OK For Eye Drug; Preliminary Data From Phase III Trial Show Lucentis Is the First Investigational Therapy To Demonstrate Clinical Benefit Over Visudyne In A Head-to-Head Study Of Patients With Wet AMD

  11/8/2005

• FoxHollow Technologies Names Former Genentech, Inc. President Myrtle Potter To Its Board Of Directors

  11/7/2005

• FDA Release: OSI Pharmaceuticals, Inc. Approves First New Therapy In Nine Years For Treatment Of Advanced Pancreatic Cancer

  11/3/2005

• FDA Approves Genentech, Inc. And OSI Pharmaceuticals, Inc.'s Tarceva(R) In Combination With Gemcitabine Chemotherapy For Pancreatic Cancer

  11/3/2005

• Biogen Idec, Inc. (Massachusetts) And Genentech, Inc. Announce FDA Acceptance Of Supplemental Biologics License Application And Priority Review Designation For Rituxan(R) In Rheumatoid Arthritis

  10/31/2005

• Tanox, Inc. Release: Xolair(R) Receives Approval In Europe

  10/27/2005

• Genentech, Inc. And Biogen Idec, Inc. (Massachusetts): FDA Grants Priority Review For Rituxan(R) Supplemental Biologics License Application For Front-Line Treatment Of Intermediate-Grade Or Aggressive Non-Hodgkin's Lymphoma

  10/25/2005

• Genentech, Inc. Release: Pivotal Herceptin Data In The New England Journal of Medicine Showed Significant Improvement In Disease-Free Survival In Early-Stage HER2-Positive Breast Cancer

  10/20/2005

• Genentech, Inc. And Accelerate Brain Cancer Cure Announce Second Brain Cancer Collaboration

  10/20/2005

• Cancer Drug Found To Cut Some Relapses By Half

  10/20/2005

• The Day In Review: Biotech Falls Despite Genentech

  10/11/2005

• Biotech Growth Puts Life In Sleepy Market; Millions Of Square Feet Being Built

  8/29/2005

• Genentech Shares May See Upside On Herceptin Strength

  8/19/2005